Senior regulatory health project manager for the generic drug user fee amendments gdufa
Ended Purchase Order Awarded Last action
- Contract number
- HHSF223201710162P
- Awardee
-
Caitta Inc. UEI LA8YGEWUDJK4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $59,216
Award facts
- Opportunity
-
- FDARFQ1178545 Solicitation number
- Contract value 32% obligated
-
- $59,216.06 Current, with exercised options
- $183,977.66 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- 8(a) Sole Source
- Competition
- Not Available for Competition · 1 offer Only One Source
- Pricing
- Labor Hours
- Place of performance
- Herndon, VA 20170, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$112,504 | |
| Exercise an Option | $59,184 | |
| Exercise an Option | $57,240 | |
| Original award | $55,296 |
About this award
This is a sole source 8(a) set aside contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Caitta Inc., an SBA certified economically disadvantaged woman-owned small business. The contract is for a Senior Regulatory Health Project Manager to support the Generic Drug User Fee Amendments (GDUFA) program, with a potential value of $183,977.66 and a completion date of August 6, 2022. Caitta is a prime contractor that provides scientific, technical, and administrative services to federal agencies, including the FDA, NIH, and NIST, with a focus on public health and regulatory functions. The company holds multiple indefinite delivery vehicles with federal clients, including a $2 million General Services Administration Federal Supply Schedule contract and a sole source 8(a) set aside contract from the FDA for benefit, risk, and quality assessment services.
Quick answers
Who was awarded contract HHSF223201710162P?
HHSF223201710162P was awarded to Caitta Inc. by Food and Drug Administration (Department of Health and Human Services) on July 5, 2017.
How much is contract HHSF223201710162P worth?
The government has obligated $59,216 on HHSF223201710162P. Its potential value, with all options, is $183,978.
Was contract HHSF223201710162P competed?
The extent of competition for HHSF223201710162P was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award